FRT
60
2
PVH
47
4
VFC
79
3
KMI
59
6
HD
34
6
F
62
2
DUK
45
-2
ISRG
64
-2
HUM
37
3
OMC
69
4
D
35
-2
AMZN
53
-2
SE
43
2
AFL
42
3
DD
57
2
AAP
24
-3
SBUX
39
4
HSY
35
3
AAL
51
-2
LEG
64
5
FRT
60
2
PVH
47
4
VFC
79
3
KMI
59
6
HD
34
6
F
62
2
DUK
45
-2
ISRG
64
-2
HUM
37
3
OMC
69
4
D
35
-2
AMZN
53
-2
SE
43
2
AFL
42
3
DD
57
2
AAP
24
-3
SBUX
39
4
HSY
35
3
AAL
51
-2
LEG
64
5
Financhill
Back

Avista Corp. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
41

AVA
Avista Corp.

Last Price:
$38.75
Seasonality Move:
5.24%
Sell
33

NKTR
Nektar Therapeutics

Last Price:
$51.10
Seasonality Move:
11.58%
Sell
41
Avista Corp. (AVA) is a Sell

Is Avista Corp. a Buy, Sell or Hold?

  • The current Avista Corp. [AVA] share price is $38.75. The Score for AVA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • AVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AVA Stock Price Chart

What is Avista Corp.'s stock price today?

  • The Avista Corp. share price today is $38.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVA is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $51.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

AVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 40.3 Sell
Chaikin Money Flow: -421362 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.2 - 41.5) Sell
Bollinger Bands (100): (36.48 - 39.7) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -893008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.73 - 61.07) Sell
Bollinger Bands (100): (32.3 - 62.42) Buy

AVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.76 Sell
20-day SMA: 40.14 Sell
50-day SMA: 39.23 Sell
200-day SMA: 38.7 Buy
8-day EMA: 38.98 Sell
20-day EMA: 39.56 Sell
50-day EMA: 39.25 Sell
200-day EMA: 38.37 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.44 Sell
20-day SMA: 58.08 Sell
50-day SMA: 58.52 Sell
200-day SMA: 30.43 Buy
8-day EMA: 56.58 Sell
20-day EMA: 57.71 Sell
50-day EMA: 55.82 Sell
200-day EMA: 37.69 Buy

Avista Corp. Earnings Growth & AVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.25 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Avista Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):